Communications of the ACM
ACM News
se of Personalized Cancer Drugs Runs Ahead of the Science
More than 30% of cancer drugs are prescribed to treat conditions for which they have not been specifically approved.
Credit: Hero Images/Getty
As the costs of genetic sequencing fall, oncologists are starting to prescribe expensive new drugs that target the genetic profiles of their patients' tumours, even when those treatments have not been approved for the particular cancer involved.
From Nature
View Full Article
No entries found